Company Shire PLC Nasdaq

Equities

SHPG

US82481R1068

Pharmaceuticals

Delayed Nasdaq 5-day change 1st Jan Change
- USD -.--% Intraday chart for Shire PLC +3.58% +2.96%

Business Summary

Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows:

- sales of products (95.3%);

- other (4.7%): primarily franchise royalties.

Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).

Managers

Managers TitleAgeSince
Director/Board Member - 19-01-07
Corporate Officer/Principal - -
Human Resources Officer - 12-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 925,620,398 0 7,500,000 ( 0.8103 %) -

Company contact information

Shire Plc

Miesian Plaza 50-58 Baggot Street Lower

2, Dublin

+353 1 609 6000

http://www.shire.com
address Shire PLC(SHPG)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Shire Services BV
Pharmaceuticals: Major
Pharmaceuticals: Major
Shire Licensing VOF